Perfusion MR Imaging in Gliomas: Comparison with Histologic Tumor Grade

Objective

To determine the usefulness of perfusion MR imaging in assessing the histologic grade of cerebral gliomas.

Materials and Methods

In order to determine relative cerebral blood volume (rCBV), 22 patients with pathologically proven gliomas (9 glioblastomas, 9 anaplastic gliomas and 4 low-grade gliomas) underwent dynamic contrast-enhanced T2*-weighted and conventional T1- and T2-weighted imaging. rCBV maps were obtained by fitting a gamma-variate function to the contrast material concentration versus time curve. rCBV ratios between tumor and normal white matter (maximum rCBV of tumor / rCBV of contralateral white matter) were calculated and compared between glioblastomas, anaplastic gliomas and low-grade gliomas.

Results

Mean rCBV ratios were 4.90°±1.01 for glioblastomas, 3.97°±0.56 for anaplastic gliomas and 1.75°±1.51 for low-grade gliomas, and were thus significantly different; p < .05 between glioblastomas and anaplastic gliomas, p < .05 between anaplastic gliomas and low-grade gliomas, p < .01 between glioblastomas and low-grade gliomas. The rCBV ratio cutoff value which permitted discrimination between high-grade (glioblastomas and anaplastic gliomas) and low-grade gliomas was 2.60, and the sensitivity and specificity of this value were 100% and 75%, respectively.

Conclusion

Perfusion MR imaging is a useful and reliable technique for estimating the histologic grade of gliomas.     

最小表观弥散系数对颅内少突胶质肿瘤分级及分型的价值

目的:评价最小表观弥散系数对颅内少突胶质肿瘤分级及分型的价值.材料和方法:24个病理证实为少突胶质肿瘤的病人(男性13人,女性11人,平均年龄45岁),包括4个Ⅲ级(间变型)少突星形细胞瘤(oligoastrocytomas,OA),6个Ⅲ级(间变型)少突胶质瘤(oligodendrogliomas,OD),2个Ⅱ级少突星形细胞瘤和12个Ⅱ级少突胶质瘤共4组.在肿瘤实质部分测定最小表观弥散系数(minimum apparent diffusion coefficient,AD Cmin)值及对侧正常脑白质的ADC值,并计算其相对值(relative ADCmin).比较不同分级及病理分型组间平均rADCmin值并统计分析.结果:不同分型少突胶质肿瘤平均rADCmin分别为Ⅲ级OA0.95±0.05,Ⅲ级OD1.11±0.30,Ⅱ级OA1.69±0.59,Ⅱ级OD1.45±0.41,与肿瘤分级及恶性程度呈负相关(P=0.004).rADCmin在两种级别少突胶质肿瘤中有显著性差异(P=0.014), 进一步两两比较显示rADCmin在Ⅲ级OA与Ⅱ级OD,Ⅱ级OA之间均有显著性差异(P=0.027,P=0.029).但Ⅲ级OD与Ⅱ级OD,Ⅱ级OA其平均rADCmin无显著性差异(P=0.067～0.081);当分界值rADCmin=1.03时鉴别Ⅱ级少突胶质肿瘤与Ⅲ级OA的敏感度为100%,特异度100%,但鉴别两种级别的少突胶质肿瘤敏感度仅60%,特异度100%.结论:rADCmin可以为少突胶质肿瘤分级提供有价值的信息,选择最适分界值rADCmin=1.03,可以鉴别Ⅲ级少突星形细胞瘤和Ⅱ级少突胶质肿瘤;但由于Ⅲ级OD其rADCmin与其余各组的交叉重叠,单独应用rADCmin鉴别两种级别肿瘤价值有限,rADCmin小于1.03可排除Ⅱ级少突胶质肿瘤.     

弥散张量成像相对各向异性值和相对表观系数值在评价脑胶质瘤级别中的研究

目的 探讨弥散张量成像(DTI)相对各向异性(rFA)值和相对表观系数(rADC)值在评价脑胶质瘤病理等级中的应用价值.方法 对27 例经手术及组织病理学证实的胶质瘤患者,术前行常规MRI、DTI 检查.在FA 图上,感兴趣区分别设定在瘤体实质部(FA1)、瘤体边缘(FA2),周围水肿(FA3),以及对侧半球皮质脊髓束(FAc),测量出FA1、FA2、FA3及FAc 值;在相同层面ADC 图上同位置,测量出ADC1、ADC2 、ADC3及ADCc 值,计算出相对FA值(rFA1-3)和相对ADC 值(rADC1-3), rFA、rADC 与胶质瘤的病理级别之间关系进行统计学处理.结果 27例胶质瘤患者,其中低级别胶质瘤(WHO grade I～ II )14 例,高级别胶质瘤(WHO grade III～IV)13例.肿瘤实质部rFA1值与肿瘤级别无显著相关性(r＝0.328,P＞0.05),肿瘤边缘的rFA2值高级别胶质瘤高于低级别(t=2.453,P＜0.05),水肿区高级别胶质瘤的rFA3值低于低级别(t=2.318, P＜0.05);肿瘤实质部rADC1值、肿瘤边缘rADC2值与肿瘤恶性程度存在显著负相关(r分别为-0.393、-0.404, P值均＜0.05),水肿区高级别胶质瘤的rADC3值高于低级别(t=4.715, P＜0.01).结论 胶质瘤边缘的rFA2值、水肿区rFA3值及胶质瘤瘤体部、边缘、水肿区的rADC值在胶质瘤的术前病理分级诊断中具有参考价值.     

表观扩散系数在前列腺癌Gleason分级中的诊断价值

目的:研究前列腺癌灶和膀胱内尿液ADC比值与Gleason评分的关系,评价ADC在前列腺癌Gleason分级中的诊断价值.方法:使用1.5T MR扫描仪对108例前列腺癌患者进行DWI检查,b值取0和800s/mm2,分别测量中央腺和外周带癌灶和膀胱内尿液ADC值,计算两者比值;根据病理结果将中央腺和外周带癌分别分为Gleason3+3、3+4、4+3、≥4+4四组,将ADC比值与Gleason评分进行比较、分析.结果:中央腺和外周带前列腺癌灶与膀胱内尿液ADC比值与Gleason评分均呈负相关(中央腺r=-0.58,P＜0.01;外周带r=-0.804,P＜0.01).以比值0.225为临界点,中央腺区分低中分化和高分化前列腺癌的诊断敏感性71.5％,特异度85％;以比值0.215为临界点,外周带区分低中分化和高分化前列腺癌的诊断敏感性82.6％,特异度87.5％.结论:前列腺癌ADC值与Gleason评分呈负相关关系,ADC有助于前列腺癌的分级判定.     

脑胶质瘤灌注成像与病理对照研究

目的运用磁共振灌注成像(PWI)获取对比剂首过期间的兴趣区图像,评价rCBV和rCBF在术前评估脑胶质瘤组织学分级中的价值.材料和方法本组共30例颅脑胶质瘤,均经病理证实.常规MRI扫描后行PWI,PWI序列为GRE-EPIRIT2*WI,由灌注资料获取rCBV、rCBF图像,计算最大rCBV和rCBF并与组织病理学分级对照.结果Ⅲ～Ⅳ级胶质瘤(18例)的rCBF、rCBV分别为1.8～7.4和2.67～10.48,均值分别为5.4±1.8和5.75±3.85.I～Ⅱ级胶质瘤(12例)rCBF、rCBV分别为0.5～1.7和1.36～3.16,均值分别为1.4±0.3和1.75±0.65.两组间rCBF和rCBV差别有显著性(P＜0.01,studentt检验).结论灌注成像对颅脑胶质瘤的术前分级有重要价值.     

二维化学位移1H-MRS对胶质瘤级别划分的价值

目的:探讨二维化学位移氢质子磁共振波谱(2DCSI1H-MRS)对不同级别胶质瘤划分的价值。方法:回顾性分析经临床诊断和(或)经手术病理证实的75例患者的MRI及MRS表现,包括Ⅱ级胶质瘤30例,Ⅲ级胶质瘤25例,Ⅳ级胶质瘤20例,计算瘤体区、瘤周水肿区及正常脑组织的胆碱(choline,Cho)、肌酸(creatine,Cr)、N-乙酰天门氡氨酸(N-acetyl aspartate,NAA)的浓度及Cho/Cr、NAA/Cr、NAA/Cho的比值。结果:①Ⅱ、Ⅲ、Ⅳ级胶质瘤瘤体区的Cho/Cr分别为1.62±0.42、2.46±1.82、3.03±1.51,瘤水肿周区的Cho/Cr分别为0.86±0.45、1.36±0.74、1.76±0.64,差异均有统计学意义(P<0.05);②与对侧正常脑组织比较,在瘤体区三组胶质瘤各值均有差异,在瘤周水肿区Ⅱ级胶质瘤Cho、NAA有差异,Ⅲ、Ⅳ级胶质瘤各值均有差异;③当取瘤体区Cho/Cr>2,瘤周区Cho/Cr>1时,鉴别高级别(Ⅲ、Ⅳ级)胶质瘤的敏感度、特异度、阳性预测值、阴性预测值分别为80.9%、70.1%、87.9%、60.1%和83.5%、74.2%、88.5%、73.6%;④当MRI与MRS联合使用时,鉴别高低级胶质瘤的敏感度、特异度、PPV、NPV均较单独采用其中一种方法时提高。结论:2DCSI1H-MRS可以有效鉴别不同级别胶质瘤,MRI与MRS联合使用时临床价值更高。     

脑胶质瘤磁共振灌注成像与病理对照研究

目的　评价磁共振灌注成像在术前评估脑胶质瘤组织病理学分级中的价值。方法　经手术及病理证实的胶质瘤共 2 6例。行常规MR及MR灌注成像检查。构建脑血流容积 (CBV)图和脑血流量 (CBF)图 ,计算最大相对CBV(rCBV)和最大相对CBF(rCBF) ,并与组织病理学分级对照。结果　低级组 (Ⅰ～Ⅱ级 )胶质瘤rCBV、rCBF范围分别为 0 .72～ 4.2 6和 0 .82～ 2 .89,均值分别为 2 .10± 1.18和 1.5 2± 0 .65。高级组 (Ⅲ～Ⅳ级 )胶质瘤rCBV、rCBF范围分别为 0 .89～ 10 .0 2和 1.5 0～ 6.40 ,均值分别为 5 .2 3± 1.86和 4.81± 2 .60。 2组rCBV和rCBF差别有显著性 (t检验 ,Ρ <0 .0 1)。非参数相关性分析表明rCBV与rCBF间有显著的正相关性 (r =0 .712 ,Ρ <0 .0 1)。结论　脑磁共振灌注成像对胶质瘤的术前分级有重要临床意义。     

高级别胶质瘤和转移瘤的磁共振波谱及灌注成像研究

目的通过磁共振波谱(MRS)及灌注成像(PI)研究肿瘤强化区域、肿瘤周围区域的细胞代谢和血管分布特点,探讨MRS及PI对高级别胶质瘤和转移瘤的鉴别诊断价值。资料与方法23例颅内肿瘤患者,包括高级别胶质瘤(Ⅲ～Ⅳ级)13例,转移瘤10例,行常规MRI、PI和单体素MRS检查。MRS检查主要观察的代谢物有:氮-乙酰天门冬氨酸(NAA),胆碱(Cho),肌酸(Cr/PCr),计算NAA/Cr,Cho/Cr,NAA/Cho比值。PI观察指标为相对脑血容量(rCBV)。采用SPSS10.0软件进行统计学分析。结果MRS提示高级别胶质瘤和转移瘤肿瘤强化区域均出现NAA/Cr与NAA/Cho降低,Cho/Cr升高;两种肿瘤强化区域各项比值之间的比较差异均无统计学意义(P>0.05);高级别胶质瘤肿瘤周围组织亦出现NAA/Cr与NAA/Cho降低,Cho/Cr升高,与转移瘤肿瘤周围组织相比差异均有统计学意义(P<0.05)。高级别胶质瘤和转移瘤肿瘤强化区域的rCBV值分别为4.05±2.04,3.84±2.44,两者之间差异无统计学意义(P>0.05),肿瘤周围组织的rCBV值分别为1.31±0.14,0.56±0.22,两者之间差异有统计学意义(P<0.05)。结论结合肿瘤强化区域与肿瘤周围区域的MRS和PI,有助于提高对高级别胶质瘤和转移瘤的鉴别能力。     

Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis

BACKGROUND:Brain imaging in diffuse glioma is used for diagnosis, treatment planning, and follow-up.PURPOSE:In this meta-analysis, we address the diagnostic accuracy of imaging to delineate diffuse glioma.DATA SOURCES:We systematically searched studies of adults with diffuse gliomas and correlation of imaging with histopathology.STUDY SELECTION:Study inclusion was based on quality criteria. Individual patient data were used, if available.DATA ANALYSIS:A hierarchic summary receiver operating characteristic method was applied. Low- and high-grade gliomas were analyzed in subgroups.DATA SYNTHESIS:Sixty-one studies described 3532 samples in 1309 patients. The mean Standard for Reporting of Diagnostic Accuracy score (13/25) indicated suboptimal reporting quality. For diffuse gliomas as a whole, the diagnostic accuracy was best with T2-weighted imaging, measured as area under the curve, false-positive rate, true-positive rate, and diagnostic odds ratio of 95.6%, 3.3%, 82%, and 152. For low-grade gliomas, the diagnostic accuracy of T2-weighted imaging as a reference was 89.0%, 0.4%, 44.7%, and 205; and for high-grade gliomas, with T1-weighted gadolinium-enhanced MR imaging as a reference, it was 80.7%, 16.8%, 73.3%, and 14.8. In high-grade gliomas, MR spectroscopy (85.7%, 35.0%, 85.7%, and 12.4) and ¹¹C methionine–PET (85.1%, 38.7%, 93.7%, and 26.6) performed better than the reference imaging.LIMITATIONS:True-negative samples were underrepresented in these data, so false-positive rates are probably less reliable than true-positive rates. Multimodality imaging data were unavailable.CONCLUSIONS:The diagnostic accuracy of commonly used imaging is better for delineation of low-grade gliomas than high-grade gliomas on the basis of limited evidence. Improvement is indicated from advanced techniques, such as MR spectroscopy and PET.

Diffuse gliomas are the most common primary brain tumors in adults, with an annual incidence of approximately 6 per 100,000. Despite advances in neurosurgery, radiation therapy, and chemotherapy, gliomas are fatal.¹ Brain imaging is indispensable for diagnosis, treatment planning, evaluation, and follow-up. Although imaging standards to plan resection and radiation therapy vary between institutions and specialists, conventional imaging is in common use, typically consisting of T1-weighted MR imaging before and after gadolinium and T2/FLAIR-weighted imaging for gliomas. Of these conventional sequences, T2/FLAIR-weighted imaging is often considered as a reference for low-grade gliomas, and T1-weighted gadolinium-enhanced imaging, for high-grade gliomas in neurosurgical planning, combined with T2-weighted imaging in radiation therapy planning.^2,3Compared with other cancer types, accurate delineation of gliomas within the brain for treatment planning is particularly important due to the proximity of eloquent brain structures, which are vulnerable to surgery and radiation therapy.⁴ Conversely, more extensive resections and boosted radiation therapy correlate with longer survival.^5–7 At the same time, clinical observations challenge the diagnostic accuracy of current imaging protocols: Gliomas recur even after a radiologically complete resection,^8,9 and glioma cells have been detected outside MR imaging abnormalities.^10,11 Brain imaging techniques, such as multivoxel spectroscopy and PET, were developed to improve tumor grading and delineation.^12,13Inherent in any regional treatment, such as surgery and radiation therapy, is the need to delineate a target volume, which mandates a dichotomous classification into tumor and normal tissue. Low- and high-grade gliomas have different treatment strategies and prognosis, while both are characterized by diffuse tumor infiltration. This supports our pooled analysis for diffuse glioma in addition to subgroup analysis by glioma grade. More accurate glioma delineation may improve the consistency between treatment results and survival. For instance, more accurate delineation may serve to identify patients eligible for more aggressive surgery than would have been considered on the basis of conventional imaging and may identify patients with glioma infiltration beyond meaningful surgical therapy so that useless and possibly harmful resections can be avoided.The diagnostic accuracy of imaging techniques to delineate gliomas has not been systematically addressed, to our knowledge. In this meta-analysis, we estimate and compare the diagnostic accuracies of conventional imaging techniques and advanced MR imaging and PET to delineate newly diagnosed diffuse gliomas within brain tissue in adults.     

磁共振扩散张量成像在星形细胞瘤分级中的价值

目的 探讨磁共振扩散张量成像（DTI）技术在星形细胞瘤分级中的应用价值。资料与方法对15例1-2级星形细胞瘤及22例3～4级星形细胞瘤进行了MR检查,扫描序列包括T1WI、T2WI、液体衰减反转恢复序列（FLAIR）、DTI及增强后T1WI。结果脑部分各向异性指数（FA）图、FA彩色编码图、纤维束追踪图均能显示脑白质纤维受累情况,而常规MRI难以显示。1—2级星形细胞瘤组肿瘤区表观扩散系数（ADC）值（1．33±0．17）与3—4级星形细胞瘤组肿瘤区ADC值（1.17±0．21）比较差异有统计学意义（P〈0．05）。两组瘤周白质FA值与ADC值比较差异均有统计学意义。结论DTI可无创性显示脑自质纤维,且肿瘤区ADC值对星形细胞瘤良恶性分级有重要价值。     

Deep Learning-based Noise Reduction for Fast Volume Diffusion Tensor Imaging: Assessing the Noise Reduction Effect and Reliability of Diffusion Metrics

To assess the feasibility of a denoising approach with deep learning-based reconstruction (dDLR) for fast volume simultaneous multi-slice diffusion tensor imaging of the brain, noise reduction effects and the reliability of diffusion metrics were evaluated with 20 patients. Image noise was significantly decreased with dDLR. Although fractional anisotropy (FA) of deep gray matter was overestimated when the number of image acquisitions was one (NAQ1), FA in NAQ1 with dDLR became closer to that in NAQ5.     

高b值扩散加权成像对胶质瘤分级的应用价值

目的评价高b值MR扩散加权成像(diffusion weighted imaging,DWI)对胶质瘤分级的应用价值。资料与方法经手术病理证实的36例胶质瘤(高级23例,低级13例)患者行常规MRI和DWI检查,分析其DWI表现。测量低、中、高b值(b=600 s/mm2、1000 s/mm2、3000 s/mm2)DWI图像中不同级别胶质瘤的肿瘤实性区域与对侧相应部位正常脑白质区的信号强度(SI)和表观扩散系数(ADC)值,计算肿瘤与正常区SI的比值即相对信号强度(rSI)和ADC的比值即相对ADC值(rADC)。结果 (1)在高b值时,21例(91.3%)高级胶质瘤呈高信号,而12例(92.3%)低级胶质瘤呈低信号。(2)在b值相同时,高级胶质瘤的平均rSI明显高于低级胶质瘤,平均ADC值、平均rADC值明显低于低级胶质瘤,两组之间的差异均有统计学意义(P<0.0001),其中rSI以及rADC的差异在高b值时更大。(3)对于高级胶质瘤,在高b值与中b值、高b值与低b值比较时平均rSI值以及平均rADC值的差异均有统计学意义(P<0.0001);对于低级胶质瘤,在高b值与中b值、高b值与低b值比较时平均r...     

弥散峰度成像对高级别脑胶质瘤和单发脑转移瘤的鉴别价值研究

目的 探讨弥散峰度成像(DKI)对鉴别高级别脑胶质瘤和单发脑转移瘤的临床应用价值.方法 搜集经病理或临床证实的33例脑肿瘤患者纳入研究,其中高级别胶质瘤18例,单发脑转移瘤15例,分别行常规磁共振平扫、DKI及常规增强扫描.经后处理分别得到DKI相关参量图,分别测量在肿瘤实性部分、瘤周水肿区域的各参数值.采用两样本t检验,分析高级别脑胶质瘤与单发脑转移瘤实质部分和瘤周水肿区域的各相对参数值平均弥散峰度(MK)、部分各向异性(FA)、平均扩散系数(MD),分析差异有无统计学意义.结果 在肿瘤实质部分,高级别脑胶质瘤和单发脑转移瘤MK、FA、MD各相对参数值比较,差异均无统计学意义(P值分别为0.529、0.645、0.84).在瘤周水肿区域,高级别胶质瘤和单发脑转移瘤MK、FA、MD各相对参数值比较,差异均有统计学意义(P值分别为0.002、0.003、0.04).结论 (1)DKI各相对参数MK、FA、MD在肿瘤实质部分对鉴别高级别脑胶质瘤和单发脑转移瘤没有明显价值.(2) DKI各相对参数MK、FA、MD在瘤周水肿区域对高级别脑胶质瘤和单发脑转移瘤有鉴别诊断价值.     

MR扩散、灌注成像在脑胶质瘤分级中的价值

目的评价MR扩散、灌注成像在脑胶质瘤病理分级诊断中的价值.资料与方法对经组织病理学证实的28例脑胶质瘤患者(19例高级别胶质瘤,9例低级别胶质瘤),术前行常规MR平扫,MR扩散成像、灌注成像和常规增强扫描,重建出表观扩散系数(ADC)彩图和相对脑血流容量(rCBV)彩图后,分别测量出肿瘤实质部分的最小ADC值和最大rCBV值.用两样本t检验分析肿瘤的ADC值、rCBV值与术后病理学分级间的关系,用线性回归分析ADC值与rCBV值间的关系.结果 19例高级别胶质瘤的平均最小ADC值为(0.95±0.29)×10-3 mm2/s;9例低级别胶质瘤的平均最小ADC值为(1.37±0.16)×10-3 mm2/s,两组间ADC值有统计学显著性差异(t=4.09,P<0.001).高级别胶质瘤的平均最大rCBV值为5.49±1.87;低级别胶质瘤的平均最大rCBV值为1.70±0.73,两组间rCBV值有统计学显著性差异(t=5.89,P<0.001).此外,ADC值与rCBV值间有统计学显著负线性相关性(r＝-0.51,P<0.05).结论 MR扩散、灌注成像能提供常规MRI所不能获取的诊断信息,更低的ADC值和更高的rCBV值提示为高级别胶质瘤;更高的ADC值和更低的rCBV值提示为低级别胶质瘤,它们对脑胶质瘤的术前分级诊断具有重要价值.     

Exploratory Study of Apparent Diffusion Coefficient Histogram Metrics in Assessing Pancreatic Malignancy

PurposeTo evaluate whole-lesion 3D-histogram apparent diffusion coefficient (ADC) metrics for assessment of pancreatic malignancy.MethodsForty-two pancreatic malignancies (36 pancreatic adenocarcinoma [PDAC], 6 pancreatic neuroendocrine [PanNET]) underwent abdominal magnetic resonance imaging (MRI) with diffusion-weighted imaging before endoscopic ultrasound biopsy or surgical resection. Two radiologists independently placed 3D volumes of interest to derive whole-lesion histogram ADC metrics. Mann-Whitney tests and receiver operating characteristic analyses were used to assess metrics’ diagnostic performance for lesion histology, T-stage, N-stage, and grade.ResultsWhole-lesion ADC histogram metrics lower in PDACs than PanNETs for both readers (P ≤ .026) were mean ADC (area under the curve [AUC] = 0.787-0.792), mean of the bottom 10th percentile (mean_0-10) (AUC = 0.787-0.880), mean of the 10th-25th percentile (mean_10-25) (AUC = 0.884-0.917) and mean of the 25th-50th percentile (mean_25-50) (AUC = 0.829-0.829). For mean_10-25 (metric with highest AUC for identifying PDAC), for reader 1 a threshold > 0.94 × 10^?3 mm²/s achieved sensitivity 94% and specificity 83%, and for reader 2 a threshold > 0.82 achieved sensitivity 97% and specificity 67%. Metrics lower in nodal status ≥ N₁ than N₀ for both readers (P ≤ .043) were mean_0-10 (AUC = 0.789-0.822) and mean_10-25 (AUC = 0.800-0.822). For mean_10-25 (metric with highest AUC for identifying N₀), for reader 1 a threshold <1.17 achieved sensitivity 87% and specificity 67%, and for reader 2 a threshold <1.04 achieved sensitivity 87% and specificity 83%. No metric was associated with T-stage (P > .195) or grade (P > .215).ConclusionVolumetric ADC histogram metrics may serve as non-invasive biomarkers of pancreatic malignancy. Mean_10-25 outperformed standard mean for lesion histology and nodal status, supporting the role of histogram analysis.     

原发性脑淋巴瘤与高级别脑胶质瘤的MR灌注成像对照研究

目的 评价MR灌注成像鉴别诊断原发性脑淋巴瘤和高级别脑胶质瘤的价值.资料与方法 对经手术病理或定向穿刺活检证实的11例原发性脑淋巴瘤行MRI常规平扫、MR灌注成像和增强扫描.另随机搜集经手术病理证实的25例胶质母细胞瘤患者资料,用于MR灌注成像对比研究.MR灌注成像采用动态磁敏感性对比增强技术,计算每例肿瘤最大相对脑血容量(rCBV)比值和相对平均通过时间(rMTT)比值,用两样本t检验,比较分析原发性脑淋巴瘤和胶质母细胞瘤的平均最大rCBV比值和平均rMTT比值.结果 增强后11例脑淋巴瘤均有强化,其中7例重度强化、3例中重度强化、1例中度强化;25例脑胶质母细胞瘤的实质部分多呈不均匀性中重度强化,肿瘤内有不同程度的坏死和囊变.11例原发性脑淋巴瘤的平均最大rCBV比值为2.05、平均rMTT比值为1.07;25例胶质母细胞瘤的平均最大rCBV比值为6.78、平均rMTT比值为1.04.两者之间平均最大rCBV比值差异有统计学意义(t=8.15,P＜0.01)、平均rMTT比值差异无统计学意义(t=0.96,P＞0.05).结论 原发性脑淋巴瘤具有低rCBV比值的趋势,结合其常规MRI表现,MR灌注成像可作为鉴别原发性脑淋巴瘤与高级别脑胶质瘤的一种有效的方法 .